SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (3166)9/3/2002 8:36:41 AM
From: nigel bates  Respond to of 10345
 
I don't know if it has been noted...

Yep. <g>
Message 17931340

As for 'Shelly Bay Holdings', can't help yet - though apparently there is a Shelly Bay in Bermuda.

nig



To: Icebrg who wrote (3166)9/10/2002 12:40:37 PM
From: Icebrg  Read Replies (1) | Respond to of 10345
 
FDA approves Teva's cefaclor ER tablets
06 Sep 2002

The FDA has approved Teva Pharmaceutical's ANDA for cefaclor extended release tablets USP, 375mg and 500mg.
This is the first generic approval for the 375mg strength. Shipment of this product is expected to begin immediately.

Cefaclor extended release tablets are the AB-rated generic equivalent of Eli Lilly's Ceclor CD, marketed by Elan Corporation.

Cefaclor extended release tablets are a cephalosporin antibiotic with annual sales of $14 million.


datamonitor.com

As far as I see this was not a major set-back for Elan. The drug was already generic and Elan took a write-down of their IP in their 2001 accounts with an amount of mUSD 94,2. Sales during 2001 were 13,4 mUSD.

Ice (posted for reference purposes mainly).



To: Icebrg who wrote (3166)10/22/2002 7:37:00 AM
From: nigel bates  Respond to of 10345
 
Shelly Bay disposed of 1.8m Vernalis on the 10th - apparently to the MPM Capital fund run by K. van Emster.

SCHEDULE 10

NOTIFICATION OF MAJOR INTERESTS IN SHARES

All relevant boxes should be completed in block capital letters.

1. Name of company 2. Name of shareholder having a major
interest
Vernalis Group plc
Shelly Bay Holdings Limited

3. Please state whether notification 4. Name of the registered holder(s) and,
indicates that it is in respect if more than one holder, the number of
of holding of the shareholder shares held by each of them
named in 2 above or in respect of
a non-beneficial interest or in Edson Moore Corp
the case of an individual holder
if it is a holding of that
person's spouse or children under
the age of 18

As above

5. Number of 6. Percentage of 7. Number of shares 8. Percentage of
shares/amount issued class /amount of stock issued class
of stock disposed
acquired N/A 4.19%
1,800,000
N/A

9. Class of security 10. Date of 11. Date company
transaction informed
Ordinary 10p shares
Not Disclosed 21st October 2002

12. Total holding following this 13. Total percentage holding of issued
notification class following this notification

1,143,396 2.66%

14. Any additional information 15. Name of contact and telephone number
for queries

Richard Robinski - 0118 977 3133